Literature DB >> 12080106

Membrane structure of the human immunodeficiency virus gp41 fusion domain by molecular dynamics simulation.

Shantaram Kamath1, Tuck C Wong.   

Abstract

The structures of the 16-residue fusion domain (or fusion peptide, FP) of the human immunodeficiency virus gp41 fusion protein, two of its mutants, and a shortened peptide (5-16) were studied by molecular dynamics simulation in an explicit palmitoyloleoylphosphoethanolamine bilayer. The simulations showed that the active wild-type FP inserts into the bilayer approximately 44 degrees +/- 6 degrees with respect to the bilayer normal, whereas the inactive V2E and L9R mutants and the inactive 5 to 16 fragment lie on the bilayer surface. This is the first demonstration by explicit molecular dynamics of the oblique insertion of the fusion domain into lipid bilayers, and provides correlation between the mode of insertion and the fusogenic activity of these peptides. The membrane structure of the wild-type FP is remarkably similar to that of the influenza HA(2) FP as determined by nuclear magnetic resonance and electron spin resistance power saturation. The secondary structures of the wild-type FP and the two inactive mutants are quite similar, indicating that the secondary structure of this fusion domain plays little or no role in affecting the fusogenic activity of the fusion peptide. The insertion of the wild-type FP increases the thickness of the interfacial area of the bilayer by disrupting the hydrocarbon chains and extending the interfacial area toward the head group region, an effect that was not observed in the inactive FPs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12080106      PMCID: PMC1302133          DOI: 10.1016/S0006-3495(02)75155-2

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  32 in total

1.  Factors important for fusogenic activity of peptides: molecular modeling study of analogs of fusion peptide of influenza virus hemagglutinin.

Authors:  R G Efremov; D E Nolde; P E Volynsky; A A Chernyavsky; P V Dubovskii; A S Arseniev
Journal:  FEBS Lett       Date:  1999-11-26       Impact factor: 4.124

2.  Implicit solvent model studies of the interactions of the influenza hemagglutinin fusion peptide with lipid bilayers.

Authors:  D Bechor; N Ben-Tal
Journal:  Biophys J       Date:  2001-02       Impact factor: 4.033

3.  Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin.

Authors:  X Han; J H Bushweller; D S Cafiso; L K Tamm
Journal:  Nat Struct Biol       Date:  2001-08

4.  Solid state NMR measurements of conformation and conformational distributions in the membrane-bound HIV-1 fusion peptide.

Authors:  J Yang; P D Parkanzky; B A Khunte; C G Canlas; R Yang; C M Gabrys; D P Weliky
Journal:  J Mol Graph Model       Date:  2001       Impact factor: 2.518

5.  Solid-state nuclear magnetic resonance evidence for an extended beta strand conformation of the membrane-bound HIV-1 fusion peptide.

Authors:  J Yang; C M Gabrys; D P Weliky
Journal:  Biochemistry       Date:  2001-07-10       Impact factor: 3.162

6.  Use of helical wheels to represent the structures of proteins and to identify segments with helical potential.

Authors:  M Schiffer; A B Edmundson
Journal:  Biophys J       Date:  1967-03       Impact factor: 4.033

7.  15N NMR study of the ionization properties of the influenza virus fusion peptide in zwitterionic phospholipid dispersions.

Authors:  Z Zhou; J C Macosko; D W Hughes; B G Sayer; J Hawes; R M Epand
Journal:  Biophys J       Date:  2000-05       Impact factor: 4.033

8.  Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus.

Authors:  W R Gallaher
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

9.  Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.

Authors:  M Pritsker; J Rucker; T L Hoffman; R W Doms; Y Shai
Journal:  Biochemistry       Date:  1999-08-31       Impact factor: 3.162

10.  Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.

Authors:  F D Veronese; A L DeVico; T D Copeland; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

View more
  19 in total

1.  Studies on viral fusion peptides: the distribution of lipophilic and electrostatic potential over the peptide determines the angle of insertion into a membrane.

Authors:  A Taylor; M S P Sansom
Journal:  Eur Biophys J       Date:  2010-05-25       Impact factor: 1.733

2.  A strong correlation between fusogenicity and membrane insertion depth of the HIV fusion peptide.

Authors:  Wei Qiang; Yan Sun; David P Weliky
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

3.  Solid-state nuclear magnetic resonance measurements of HIV fusion peptide 13CO to lipid 31P proximities support similar partially inserted membrane locations of the α helical and β sheet peptide structures.

Authors:  Charles M Gabrys; Wei Qiang; Yan Sun; Li Xie; Scott D Schmick; David P Weliky
Journal:  J Phys Chem A       Date:  2013-02-28       Impact factor: 2.781

4.  Conformational flexibility and strand arrangements of the membrane-associated HIV fusion peptide trimer probed by solid-state NMR spectroscopy.

Authors:  Zhaoxiong Zheng; Rong Yang; Michele L Bodner; David P Weliky
Journal:  Biochemistry       Date:  2006-10-31       Impact factor: 3.162

5.  Influence of the membrane dipole potential on peptide binding to lipid bilayers.

Authors:  Huan Zhan; Themis Lazaridis
Journal:  Biophys Chem       Date:  2011-10-30       Impact factor: 2.352

6.  Origins of resistance to the HIVgp41 viral entry inhibitor T20.

Authors:  Brian E McGillick; Trent E Balius; Sudipto Mukherjee; Robert C Rizzo
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

7.  HIV fusion peptide penetrates, disorders, and softens T-cell membrane mimics.

Authors:  Stephanie Tristram-Nagle; Rob Chan; Edgar Kooijman; Pradeep Uppamoochikkal; Wei Qiang; David P Weliky; John F Nagle
Journal:  J Mol Biol       Date:  2010-07-22       Impact factor: 5.469

8.  Bilayer conformation of fusion peptide of influenza virus hemagglutinin: a molecular dynamics simulation study.

Authors:  Qiang Huang; Cheng-Lung Chen; Andreas Herrmann
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

9.  HIV fusion peptide and its cross-linked oligomers: efficient syntheses, significance of the trimer in fusion activity, correlation of beta strand conformation with membrane cholesterol, and proximity to lipid headgroups.

Authors:  Wei Qiang; David P Weliky
Journal:  Biochemistry       Date:  2009-01-20       Impact factor: 3.162

10.  Oligomeric beta-structure of the membrane-bound HIV-1 fusion peptide formed from soluble monomers.

Authors:  Jun Yang; Mary Prorok; Francis J Castellino; David P Weliky
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.